You just read:

OncoQuest Announces Publication of Two Reports Related to Oregovomab Phase 2 Clinical Trial, the Company's Lead Investigational Drug in Frontline Ovarian Cancer

News provided by

OncoQuest Inc.

Mar 24, 2020, 06:00 ET